Page last updated: 2024-11-07

small cardioactive peptide b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

small cardioactive peptide B: neuropeptide from Aplysia [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123843
CHEMBL ID1891530
MeSH IDM0122569

Synonyms (14)

Synonym
NCGC00167203-01
scpb
84746-43-0
methionyl-asparaginyl-tyrosyl-leucyl-alanyl-phenylalanyl-prolyl-arginyl-methioninamide
met-asn-tyr-leu-ala-phe-pro-arg-met-nh2
l-methioninamide, l-methionyl-l-asparaginyl-l-tyrosyl-l-leucyl-l-alanyl-l-phenylalanyl-l-prolyl-l-arginyl-
small cardioactive peptide b
l-methioninamide, l-methionyl-l-asparginyl-l-tyrosyl-l-leucyl-l-alanyl-l-phenylalanyl-l-prolyl-l-arginyl-
CHEMBL1891530
(s)-n1-((s)-1-(((s)-1-(((s)-1-(((s)-1-((s)-2-(((s)-1-(((s)-1-amino-4-(methylthio)-1-oxobutan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(4
CS-0044556
small cardioactive peptide b (scpb)
HY-P1495
MS-32008

Research Excerpts

Effects

ExcerptReferenceRelevance
"Small cardioactive peptide B (SCPB) has an excitatory effect on both buccal neurons and musculature in numerous molluscan species. "( The molluscan neuropeptide, SCPB, increases the responsiveness of the feeding motor program of Limax maximus.
Prior, DJ; Watson, WH, 1988
)
1.72
"Small cardioactive peptide B (SCPB) has an excitatory effect on both buccal neurons and musculature in numerous molluscan species. "( The molluscan neuropeptide, SCPB, increases the responsiveness of the feeding motor program of Limax maximus.
Prior, DJ; Watson, WH, 1988
)
1.72

Dosage Studied

ExcerptRelevanceReference
" As a first-step in addressing this issue we have examined the dose-response relationship for one aspect of the 5-HT modulation (enhancement of cAMP levels in isolated clusters of sensory neurons) and compared the effects of 5-HT with three potential neurotransmitters: tryptamine, FMRFamide (Phe-Met-Arg-Phe-NH2) and small cardioactive peptideB (SCPB)."( Membrane responses and changes in cAMP levels in Aplysia sensory neurons produced by serotonin, tryptamine, FMRFamide and small cardioactive peptideB (SCPB).
Byrne, JH; Ocorr, KA, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA polymerase kappa isoform 1Homo sapiens (human)Potency23.77810.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (84)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (46.43)18.7374
1990's34 (40.48)18.2507
2000's8 (9.52)29.6817
2010's3 (3.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.71 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other88 (98.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]